Gregory E D Mullen Selected Research

ProMune (CpG 7909)

1/2010	Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults.
12/2009	A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults.
6/2009	A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals.
8/2008	Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria.
7/2007	Enhanced antibody production in mice to the malaria antigen AMA1 by CPG 7909 requires physical association of CpG and antigen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory E D Mullen Research Topics

Disease

11	Malaria 01/2012 - 07/2007
3	Hypoxia (Hypoxemia) 07/2022 - 03/2002
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 08/2017
3	Falciparum Malaria (Plasmodium falciparum Malaria) 12/2009 - 03/2006
2	Neoplasms (Cancer) 07/2022 - 01/2011
2	Inflammation (Inflammations) 12/2014 - 03/2013
1	Adenocarcinoma 07/2022
1	Carcinoma (Carcinomatosis) 07/2022
1	Asthma (Bronchial Asthma) 12/2014
1	Erythema 01/2010
1	Infections 12/2008
1	Virus Diseases (Viral Diseases) 03/2003

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 01/2012 - 03/2006
7	AntigensIBA 10/2017 - 07/2007
5	ProMune (CpG 7909)IBA 01/2010 - 07/2007
5	Aluminum Hydroxide (Algeldrate)FDA Link 01/2010 - 03/2006
3	Malaria VaccinesIBA 03/2009 - 08/2008
3	LigandsIBA 03/2009 - 03/2002
2	Biological ProductsIBA 07/2022 - 12/2008
2	Biomarkers (Surrogate Marker)IBA 07/2022 - 03/2013
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
2	Recombinant ProteinsIBA 03/2010 - 06/2009
2	OligodeoxyribonucleotidesIBA 03/2006 - 03/2003
2	ThiosemicarbazonesIBA 03/2002 - 03/2002
1	CobaltIBA 07/2022
1	CuATSMIBA 07/2022
1	fluoromisonidazoleIBA 07/2022
1	pimonidazoleIBA 07/2022
1	Oxygen (Dioxygen)IBA 07/2022
1	Staphylococcal Protein A (Protein A)IBA 01/2021
1	human FOLH1 proteinIBA 01/2021
1	SolutionsIBA 10/2017
1	Chelating AgentsIBA 10/2017
1	AllergensIBA 12/2014
1	Sialic Acid Binding Ig-like Lectin 1IBA 03/2013
1	ferric oxide (iron oxide)IBA 01/2011
1	mannide monooleateIBA 03/2010
1	Merozoite Surface Protein 1 (MSA1)IBA 01/2010
1	BuffersIBA 06/2009
1	Phosphates (Orthophosphate)IBA 06/2009
1	Hemoglobins (Hemoglobin)IBA 05/2009
1	AntibodiesIBA 12/2008
1	Histamine (Histamine Dihydrochloride)FDA Link 03/2003
1	Histamine H2 ReceptorsIBA 03/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2003
1	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 03/2002
1	MetalsIBA 03/2002
1	CopperIBA 03/2002

Therapy/Procedure

2	Therapeutics 12/2014 - 03/2013
1	Radiotherapy 07/2022
1	Immunotherapy 01/2011